Company / Capital Expenditures
enGene Holdings Inc. Capital Expenditures History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$1.5M
FY2025
5-year range
$153.0K / $1.5M
FY2022-FY2025
Trend
+60.5%
vs FY2024
Sector context
#109 of 195
Health Care
What the data says
At $1M, enGene Holdings Inc.'s capital expenditures ranks #109 of 195 in the Health Care sector. Capital Expenditures has increased for 3 consecutive years, from $153,000 in FY2022 to $1M in FY2025.
Based on SEC 10-K filings.
$1M in FY2025 with a 3-year CAGR of +113.3%.
Improved from $318,000 to $1M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +113.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#109 of 195 in Health CareTop 56% of 195This company $1.5M Sector average $117.2M
▼
-98.7% below sector average
Key checks
Key Insights
- enGene Holdings Inc.'s capital expenditures has grown for 3 consecutive years.
- 3-year CAGR of +113.3%, indicating consistent growth.
- In FY2025, capital expenditures increased 60.5% year-over-year.
- Ranks #109 out of 195 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.5M | +60.5% |
| FY2024 | $925.0K | +190.9% |
| FY2023 | $318.0K | +107.8% |
| FY2022 | $153.0K | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026